Amino-Functionalized Silica Nanoparticles: In Vitro Evaluation for Targeted Delivery and Therapy of Pancreatic Cancer

We report a method of synthesis and optimization of amino-functionalized silica nanoparticles (SiNPs) and their in vitro evaluation as targeted delivery vehicles for the potential treatment of pancreatic cancer. SiNPs can efficiently encapsulate doxorubicin and can be attached to a targeting moiety...

Full description

Bibliographic Details
Main Authors: Abbey Y. Kardys, Dhruba J. Bharali, Shaker A. Mousa
Format: Article
Language:English
Published: Hindawi Limited 2013-01-01
Series:Journal of Nanotechnology
Online Access:http://dx.doi.org/10.1155/2013/768724
id doaj-a00dc2ce084e4ede8415ed2008b338c9
record_format Article
spelling doaj-a00dc2ce084e4ede8415ed2008b338c92020-11-24T22:30:28ZengHindawi LimitedJournal of Nanotechnology1687-95031687-95112013-01-01201310.1155/2013/768724768724Amino-Functionalized Silica Nanoparticles: In Vitro Evaluation for Targeted Delivery and Therapy of Pancreatic CancerAbbey Y. Kardys0Dhruba J. Bharali1Shaker A. Mousa2Pharmaceutical Research Institute at Albany College of Pharmacy and Health Sciences, 1 Discovery Drive, Rensselaer, NY 12144, USAPharmaceutical Research Institute at Albany College of Pharmacy and Health Sciences, 1 Discovery Drive, Rensselaer, NY 12144, USAPharmaceutical Research Institute at Albany College of Pharmacy and Health Sciences, 1 Discovery Drive, Rensselaer, NY 12144, USAWe report a method of synthesis and optimization of amino-functionalized silica nanoparticles (SiNPs) and their in vitro evaluation as targeted delivery vehicles for the potential treatment of pancreatic cancer. SiNPs can efficiently encapsulate doxorubicin and can be attached to a targeting moiety such as anti-Claudin-4 (CLN4). The preferential uptake in pancreatic cancer cells, where CLN4 is overexpressed, of SiNPs when conjugated to CLN4 antibody (compared to nonconjugated SiNPs) was confirmed by confocal microscopy. SiNPs encapsulating doxorubicin had greater efficacy in MTT assays than free doxorubicin, and when conjugated to CLN4, the efficacy was dramatically increased (at 1 μM). No apparent carrier toxicity was observed when void SiNPs were used. SiNPs carrying a chemotherapeutic drug have the potential to be used as a targeted therapy for lethal cancers, such as pancreatic cancer. Also, incorporation of fluorescent probes in these SiNPs creates the possibility of their use as an imaging probe for diagnostic purposes.http://dx.doi.org/10.1155/2013/768724
collection DOAJ
language English
format Article
sources DOAJ
author Abbey Y. Kardys
Dhruba J. Bharali
Shaker A. Mousa
spellingShingle Abbey Y. Kardys
Dhruba J. Bharali
Shaker A. Mousa
Amino-Functionalized Silica Nanoparticles: In Vitro Evaluation for Targeted Delivery and Therapy of Pancreatic Cancer
Journal of Nanotechnology
author_facet Abbey Y. Kardys
Dhruba J. Bharali
Shaker A. Mousa
author_sort Abbey Y. Kardys
title Amino-Functionalized Silica Nanoparticles: In Vitro Evaluation for Targeted Delivery and Therapy of Pancreatic Cancer
title_short Amino-Functionalized Silica Nanoparticles: In Vitro Evaluation for Targeted Delivery and Therapy of Pancreatic Cancer
title_full Amino-Functionalized Silica Nanoparticles: In Vitro Evaluation for Targeted Delivery and Therapy of Pancreatic Cancer
title_fullStr Amino-Functionalized Silica Nanoparticles: In Vitro Evaluation for Targeted Delivery and Therapy of Pancreatic Cancer
title_full_unstemmed Amino-Functionalized Silica Nanoparticles: In Vitro Evaluation for Targeted Delivery and Therapy of Pancreatic Cancer
title_sort amino-functionalized silica nanoparticles: in vitro evaluation for targeted delivery and therapy of pancreatic cancer
publisher Hindawi Limited
series Journal of Nanotechnology
issn 1687-9503
1687-9511
publishDate 2013-01-01
description We report a method of synthesis and optimization of amino-functionalized silica nanoparticles (SiNPs) and their in vitro evaluation as targeted delivery vehicles for the potential treatment of pancreatic cancer. SiNPs can efficiently encapsulate doxorubicin and can be attached to a targeting moiety such as anti-Claudin-4 (CLN4). The preferential uptake in pancreatic cancer cells, where CLN4 is overexpressed, of SiNPs when conjugated to CLN4 antibody (compared to nonconjugated SiNPs) was confirmed by confocal microscopy. SiNPs encapsulating doxorubicin had greater efficacy in MTT assays than free doxorubicin, and when conjugated to CLN4, the efficacy was dramatically increased (at 1 μM). No apparent carrier toxicity was observed when void SiNPs were used. SiNPs carrying a chemotherapeutic drug have the potential to be used as a targeted therapy for lethal cancers, such as pancreatic cancer. Also, incorporation of fluorescent probes in these SiNPs creates the possibility of their use as an imaging probe for diagnostic purposes.
url http://dx.doi.org/10.1155/2013/768724
work_keys_str_mv AT abbeyykardys aminofunctionalizedsilicananoparticlesinvitroevaluationfortargeteddeliveryandtherapyofpancreaticcancer
AT dhrubajbharali aminofunctionalizedsilicananoparticlesinvitroevaluationfortargeteddeliveryandtherapyofpancreaticcancer
AT shakeramousa aminofunctionalizedsilicananoparticlesinvitroevaluationfortargeteddeliveryandtherapyofpancreaticcancer
_version_ 1725740809284747264